ACOR - Acorda Therapeutics Stock Trading

The Acorda Therapeutics (NASDAQ: ACOR) update and the technical summary table below can help you manage risk and optimize returns. Here we provide day, swing, and longer-term trading plans for ACOR, and we cover 1000 other stocks too. This is a snapshot, it was real-time when the report...

HOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced that Michael W. Rogers joined the Company’s Board of Directors. Mr. Rogers is a biopharmaceutical vet...

INBRIJA ® (levodopa inhalation powder) 2Q 2020 net revenue of $4.7 million AMPYRA ® (dalfampridine) 2Q 2020 net revenue of $26.1 million INBRIJA dispensed cartons increase 13% over 1Q 2020 Acorda Therapeutics, Inc. (NASDAQ: ACOR ) today provided a business update...